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1561-5413/Copyright ª 2014, Hong KoSummary Background/purpose: The validity of the Oxford classification of immunoglobulin
(Ig)A nephropathy has not been fully explored in the Arab population. The aim of this study
was to assess the validity of this classification in a cohort of adult Saudi patients with histolog-
ically proven IgA nephropathy.
Methods: A retrospective review of clinical and histological data of patients with biopsy-
proven IgA nephropathy diagnosed between May 1998 and May 2011 was undertaken. The study
was conducted at two institutions in Riyadh, Saudi Arabia. A total of 70 patients (46% females)
with primary IgA nephropathy were included, with a mean age of 32.2  12.9 years. The me-
dian follow-up was 3.5 years. The primary endpoint was decreased renal function, which was
defined as 50% decrease in estimated glomerular filtration rate from baseline at last follow up.
Results: Higher mesangial score and later stage of segmental glomerulosclerosis showed trends
towards correlations with a higher degree of proteinuria and lower estimated glomerular filtra-
tion rate at presentation and a higher rate of worsening of renal function, but these trends did
not reach statistical significance (p > 0.05). However, endocapillary hypercellularity and
tubular atrophy/interstitial fibrosis were significantly associated with reduced initial esti-
mated glomerular filtration rate and higher initial proteinuria. In multivariate logistic regres-
sion, the worsening of renal function was not predicted by any histologic class.
Conclusion: The Oxford classification system is a useful tool that reflects the severity of the
initial clinical presentation in Arabs with IgA nephropathy. However, it did not predict long-
term renal outcomes.of Pathology (78), College of Medicine, King Saud University, P.O. Box 2925, Riyadh 11461, Saudi
ail.com, hkfoury@ksu.edu.sa (H. Kfoury).
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30 H. Kfoury et al.背景: 在阿拉伯人群中，IgA腎病變的牛津分類法尚未通過充分的驗證。本研究以經過組織學驗證
為 IgA 腎病變的沙烏地阿拉伯成年患者為對象，對此分類法的效度進行了評估。
方法: 是次分析所涉及的個案，是從 1998 年 5 月至 2011 年 5 月間，經切片證實為原發性 IgA 腎
病變的 70位患者，女性佔 46%，平均年齡 32.2  12.9歲，均來自沙烏地阿拉伯利雅得的兩家院
所。追蹤期間中位數為 3.5 年，首要終點為腎功能下降，其定義為腎小球濾過速率 (GFR) 估算值
降幅達 50% (相對於基線)。
結果: 分析顯示，環間膜評分偏高、與較晚期節段性腎小球硬化症，均與以下呈現相關的傾向：
基線較嚴重的蛋白尿、基線較低的 GFR估算值、及追蹤期間較明顯的腎功能惡化，雖然未達統計
學意義 (p > 0.05)。然而，微血管內細胞過多、及腎小管萎縮/間質纖維化，則與基線較嚴重的蛋
白尿、及基線較低的 GFR估算值呈明顯關聯。在多變項邏輯迴歸分析中，組織學分類並未能預測
腎功能惡化的發生。
結論: 對於阿拉伯的 IgA 腎病變成年患者，牛津分類法可有效反映初期的病情嚴重性，但未能預
測腎功能的長期變化。Introduction
Immunoglobulin (Ig)A nephropathy is the most common
primary glomerulonephritis worldwide.1 Since its descrip-
tion in 1968 by Berger,2,3 several reports, reviews, and
original articles have evaluated the various aspects of IgA
nephropathy at both the clinical and pathological levels.4e7
Their main aim has been to understand its natural history,
to evaluate its prognostic parameters, and to classify cases
into prognostic categories. Therapeutic regimens may be
targeted to optimize their benefits and prevent the pro-
gression to end-stage renal disease and/or death. Although
the diagnosis of IgA nephropathy is straightforward and
based on the immunofluorescence or immunohistochemical
finding of dominant or codominant IgA on renal biopsy, the
histological features are varied. Different pathological
classifications have been offered to address these issues,8,9
and the Oxford classification is one of them.10
The prognostic value of the Oxford classification was
validated in a study in the United States.11 That study found
that the Oxford classification was valuable in predicting the
prognosis and outcome of patients with IgA nephropathy
and recommended its use. With the necessity of external
validation, we assessed the utility of the Oxford classifica-
tion in an Arab population from two different institutions in
the central region of the Kingdom of Saudi Arabia.
Methods
The study was conducted at King Khaled University Hospital
(King Saud University) and King Abdulaziz Medical City, in
Riyadh, Saudi Arabia. Ethical approval was obtained from
the Institutional Review Board of King Saud University.
Initially, 125 cases of IgA nephropathy were identified be-
tween 1998 and 2011. Fifty-five cases were lost to follow-
up. The remaining 70 patients comprised the study popu-
lation. Four pathologists reviewed the histology slides as
well as the electron photomicrographs of all cases. The
review of the renal biopsies included confirmation of the
diagnosis and categorization according to the Oxford clas-
sification. The initial proteinuria and estimated glomerular
filtration rate (eGFR) values at the time of the biopsy were
recorded. The primary endpoint was a decreased renalfunction, which was defined as at least a 50% decrease in
eGFR rate from baseline at last follow-up. All cases that
were included were reviewed by the pathologists according
to a backbone-reporting format in which detailed descrip-
tion of the four constituents (glomeruli, tubules, inter-
stitium, and blood vessels) were standardized to maintain
homogeneity in reporting. The pathologists were blinded to
all of the clinical data.
The number of the globally or segmentally sclerotic
glomeruli in each case was counted. The other histological
features in each glomerulus, if present, were evaluated,
including the cellular, fibrocellular, or fibrous crescents;
capsular adhesion; segmental necrosis; mesangial hyper-
cellularity; and endocapillary proliferation. The vascular
changes, mainly sclerosis and hyalinosis, were also
assessed. Subsequently, the cases were organized ac-
cording to the Oxford classification based on the mesangial
(M), sclerosis (S), endocapillary proliferation (E), and
interstitial fibrosis/tubular atrophy (T) scores.10 M0 meant
that the mesangial proliferation involved <50% of the
glomeruli, and M1 meant that >50% of the glomeruli
showed mesangial proliferation. The E and S scores were
rated either 0 or 1, depending on the absence or presence
of endocapillary proliferation or sclerosis, respectively.
Interstitial fibrosis and tubular atrophy were scored from
0 to 2, indicating the percentage of interstitial fibrosis and
tubular atrophy. The pathological findings, reported as per
the Oxford classification, were correlated with proteinuria
at the time of the biopsy and the progression of renal
disease at the last follow-up, which was defined as a
decrease of estimated glomerular filtration rate by 50%
from baseline. The four parameters (M, S, E, and T) of the
Oxford classification were evaluated separately and tested
for their correlation with proteinuria and the progression
of the disease.Statistical analysis
Statistical analyses were conducted by using Predictive
Analytical Software version 18.0 (PASW; IBM-SPSS, Chicago,
IL, USA). The incidence and prevalence of various glomer-
ular diseases were determined. For discrete variables,
Pearson’s Chi-square test and Fisher’s exact test were used
Table 2 Distribution of the cohort across various Oxford
histological classes.
Classification n (%)
M0 20 (28.6)
M1 50 (71.4)
S0 29 (41.4)
S1 41 (58.6)
E0 53 (75.7)
E1 17 (24.3)
T0 45 (64.3)
T1 17 (24.3)
T2 8 (11.4)
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between patients with or without evidence of kidney dis-
ease. The Student t test and Wilcoxon’s rank-sum test for
testing of continuous data were used to compare the
baseline differences between any two groups for contin-
uous measurements (e.g., baseline serum creatinine level
and age). Analysis of variance was used to compare means
in more than two groups. Regression analysis was used to
evaluate factors associated with worsening of renal
function.
Results
The characteristics of the 70 patients who met the inclu-
sion criteria are given in Table 1. The patients’ mean age
at the time of biopsy was 32.2  12.9 years, and 46% were
female. Table 1 lists the initial clinical and laboratory
characteristics of patients at baseline, prior to the kidney
biopsy procedure. Hematuria (either macroscopic or
microscopic) was present in 10 patients (18.6%). Eighteen
adults had hematuria and proteinuria (not in nephrotic
range), and other proteinuria patterns were observed in a
smaller portion of the patients (Table 1). The Oxford
classification of IgA nephropathy of the cases is shown in
Table 2.
Correlations between pathological lesions and
clinical presentation at renal biopsy
Higher mesangial score, later stage of segmental glomer-
ulosclerosis, and greater endocapillary hypercellularity
were each associated with a higher degree of proteinuria
and lower GFR, but these trends did not reach statistical
significance (Table 3). Tubular atrophy and interstitial
fibrosis, however, were associated with significantly
reduced initial eGFR and higher initial proteinuria.Table 1 Baseline clinical and laboratory characteristics of
patients with IgA nephropathy.
Characteristic Value
Age, y 32.2  13
Body mass index, kg/m2 30.7  8.7
Hypertension 27 (39)
Urine protein, g/24-h urine sample 1.98  0.97
Baseline GFR, mL/min 43.43
Duration of symptoms, y 7.80  1.92
Female 33 (47.1)
Clinical presentation
Asymptomatic hematuria 13 (18.6)
Asymptomatic hematuria/proteinuria 18 (25.7)
Gross hematuria 10 (14.3)
Nephritic syndrome 7 (10)
Nephrotic syndrome 2 (2.8)
Nephritic-nephrotic 12 (17.1)
Azotemia 20 (28.6)
Hypertension 22 (31.4)
Dialysis requirement 5 (7)
Data are presented as n (%) or mean  SD.Correlations between pathological lesions and
outcome
There were no significant differences between baseline and
last eGFR measurement for M-score or E-score. In unad-
justed analysis, the S-score [odds ratio (OR) 8.35; confi-
dence interval (CI) 1.01e69.57, p Z 0.02] and T-score (OR
2.88; CI 1.22e6.79, p Z 0.03) were significant predictors
for worsening renal function. The prevalence of worsening
of renal function was 21% in the M0 class and 18.2% in the
M1 class (p Z 0.79; Table 4). Worsening renal function was
seen in 91.7% of S1 cases in comparison to 56.9% of S0 cases
(pZ 0.02). Regarding E scores, 33.3% of E1 cases and 15.7%
of E0 cases had worsening renal function (p Z 0.16). Lo-
gistic regression analysis showed that no histological
parameter was capable of predicting the long-term
outcome of worsening of renal function after adjusting
for baseline eGFR, hypertension, age, and sex (Table 5).
Discussion
In this article, we assessed the value of the Oxford classi-
fication in relation to the clinical characteristics, the
extent of proteinuria at the time of the biopsy and the
deterioration of renal function of Arab IgA nephropathy
patients. We found that tubular atrophy and interstitial
fibrosis were associated with a reduced initial eGFR and
higher initial proteinuria. Logistic regression analysisTable 3 The relationships between baseline proteinuria
and Oxford histological classifications of kidney biopsies.
Classification Baseline proteinuria pa
M0 0.57 (0.28e1.28) 0.13
M1 1.44 (0.61e2.56)
S0 0.79 (0.24e1.37) 0.09
S1 1.68 (0.57e2.73)
E0 0.86 (0.35e1.94) 0.05
E1 1.86 (1.10e4.99)
T0 0.62 (0.34e1.19) 0.009
T1 1.79 (1.42e3.69)
T2 3.69 (1.25e5.73)
Data are presented as median (IQR).
a Calculated with the use of Kruskal-Wallis test.
Table 4 Prevalence of worsening renal function in various
Oxford classes.
Oxford class Decrease in GFR of 50% pa
M0 4/19 (21.1) 0.79
M1 8/44 (20)
S0 29/51 (56.9) 0.02
S1 11/12 (91.7)
E0 8/51 (18.9) 0.02
E1 4/12 (33.3)
T0 4/38 (10.5) 0.03
T1 4/17 (23.5)
T2 4/8 (50)
Data are presented as median (IQR).
a Calculated with the use of Kruskal-Wallis test.
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predicting the long-term outcome of worsening renal
function after adjusting for baseline eGFR, hypertension,
age, and sex. Previous studies have addressed the issue of
the typing of IgA nephropathy and the deterioration of
eGFR over time.12e15 Whereas the clinical findings, i.e.
proteinuria, play a major role in the progression of the
renal disease to end-stage kidney disease,13,16 the patho-
logical picture is an independent prognostic parameter in
the IgA nephropathy population, as outlined by the original
working group and in the validation reports of North
American and European studies.10,11,17
The histopathology of IgA nephropathy is heteroge-
neous, and the classifications according to the histopatho-
logical findings are varied. The Oxford classification is the
latest reported classification, and its application and
popularity are increasing worldwide as its prognostic value
is gradually being revealed through validation studies on
different continents. The classifications are divided into
two types according to the method used: either a single
grade8,9 or a semi-quantitative scoring system assessing the
glomerular, tubular, interstitial and vascular compartments
separately.18e20 The advantage of the scoring system is its
good correlation with the clinical progression of the pa-
tient. It has been noted that these classifications are time
consuming, however, especially in centers dealing with a
large number of biopsies; hence the advent of a grading
system based on a single grade. Furthermore, both grading
systems are clinically relevant,16,21e24 but none of the
classifications has proven superiority over arterial pressure
or proteinuria at the time of the biopsy.16Table 5 Adjusted odds ratios in various Oxford classes for
the outcomes of worsening renal function.a
Parameter Odds ratio (95% confidence interval) p
M 0.360 (0.074e1.757) 0.206
E 1.852 (0.349e9.832) 0.469
S 1.349 (0.261e6.967) 0.721
T 1.545 (0.228e10.485) 0.655
a The analysis was adjusted for baseline estimated glomerular
filtration rate, blood pressure, age and sex.The most recent Oxford classification selected four pa-
rameters as the main indicators of renal function deteriora-
tion: mesangial hypercellularity, endocapillary proliferation,
tubular atrophy/interstitial fibrosis and glomerular
segmental sclerosis.10 It is also important that the total
number of glomeruli and the numbers of glomeruli with
endocapillary proliferation, extracapillary proliferation,
global glomerulosclerosis, and segmental glomerulosclerosis
be reported. The novelty of the current classification is that it
takes into account the vertical data related to the clinical
progression of the patient, which are not considered in any
previous classifications. The consequent possibility of evalu-
ating each histological parameter in the light of the last
clinical follow-up with the known eGFR and proteinuria hel-
ped tremendously in strengthening the value of the Oxford
classification because both the IgA Network Group and the
Renal Pathology Society worked closely to outline the pa-
rameters of the Oxford classification and to validate these
different parameters.
Our study is the first report from Saudi Arabia to corre-
late the pathological parameters of the Oxford classifica-
tion for IgA nephropathy and the progress of the disease. In
the multivariate logistic regression, no histologic class
predicted the worsening of renal function. Our study is
limited by the relatively low number of patients with a
relatively short follow up and events. It is likely that a
larger study group with a greater number of events and
longer follow up would have allowed more definitive con-
clusions on the relation of Oxford histological predictors
and long term outcome.
The Oxford classification system may be a useful tool
that reflects the severity of the initial clinical presentation
in Arabs with IgA nephropathy, but it did not predict the
long-term renal outcome. Future studies may be needed to
properly evaluate the progression of IgA nephropathy in the
Arab population and to further assess the usefulness of the
Oxford classification.Conflicts of interest
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